NEWGEN2023-01-012023-03-31 NEWGEN2023-01-012023-03-31 NEWGEN2023-01-012023-03-31in-bse-fin:OneOperatingExpenses01Member NEWGEN2023-01-012023-03-31in-bse-fin:FourOperatingExpenses01Member NEWGEN2023-03-31 NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentRevenue01Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentRevenue02Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentRevenue03Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentRevenue04Member NEWGEN2023-01-012023-03-31in-bse-fin:FourReportableSegmentRevenue01Member NEWGEN2023-01-012023-03-31in-bse-fin:FourReportableSegmentRevenue02Member NEWGEN2023-01-012023-03-31in-bse-fin:FourReportableSegmentRevenue03Member NEWGEN2023-01-012023-03-31in-bse-fin:FourReportableSegmentRevenue04Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentResults01Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentResults02Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentResults03Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentResults04Member NEWGEN2023-01-012023-03-31in-bse-fin:FourReportableSegmentResults01Member NEWGEN2023-01-012023-03-31in-bse-fin:FourReportableSegmentResults02Member NEWGEN2023-01-012023-03-31in-bse-fin:FourReportableSegmentResults03Member NEWGEN2023-01-012023-03-31in-bse-fin:FourReportableSegmentResults04Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentAssets01Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentAssets02Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentAssets03Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentAssets04Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentLiabilities01Member NEWGEN2023-03-31in-bse-fin:OneReportableSegmentLiabilities01Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentLiabilities02Member NEWGEN2023-03-31in-bse-fin:OneReportableSegmentLiabilities02Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentLiabilities03Member NEWGEN2023-03-31in-bse-fin:OneReportableSegmentLiabilities03Member NEWGEN2023-01-012023-03-31in-bse-fin:OneReportableSegmentLiabilities04Member NEWGEN2023-03-31in-bse-fin:OneReportableSegmentLiabilities04Member NEWGEN2023-01-012023-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member NEWGEN2023-01-012023-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member NEWGEN2023-01-012023-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member NEWGEN2023-01-012023-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 540900 NEWGEN NOTLISTED Newgen Software Technologies Limited Equity 2022-04-01 2023-03-31 2023-05-02 2023-04-22 INR Lakhs Yearly 11:00:00 12:15:00 2023-05-02 2023-05-02 true Cash Flow Indirect Declaration of unmodified opinion Geographical 2023-01-01 2023-03-31 Audited Standalone 2834438000.00 71084000.00 2905522000.00 0.00 0.00 0.00 1194300000.00 10370000.00 53281000.00 725551000.00 1983502000.00 922020000.00 0.00 922020000.00 177962000.00 -19747000.00 158215000.00 0.00 763805000.00 0.00 0.00 0.00 0.00 763805000.00 16509000.00 780314000.00 16509000.00 780314000.00 696557000.00 10 10.97 10.73 0.00 0.00 10.97 10.73 Statement of Standalone and Consolidated Financial Results of Newgen Software Technologies Limited for the quarter and year ended 31 March 2023 Notes 1.The above financial results for the quarter and year ended 31 March 2023 were reviewed by the Audit Committee in their meeting held on 1 May 2023 and approved by the Board of Directors in their meeting held on 2 May 2023. Standalone and Consolidated financial results of the Company for the quarter and year ended 31 March 2023 are prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and relevant rules thereunder. 2.The auditors have carried out audit of Standalone and Consolidated results of the Company for the year ended 31 March 2023. There are no qualifications in the Auditor's report on these financial results.The figures for the quarter ended 31 March 2023 and 31 March 2022 are the balancing figures between the audited figures for full financial year and the unaudited figures upto the nine months ended 31 December 2022 and 31 December 2021, respectively, which were subjected to limited review by the statutory auditors. 3.The Board of Directors in their meeting held on 2 May 2023 recommended a dividend of INR 5.00 per equity share for the financial year ended 31 March 2023. The payment is subject to approval of shareholders at the ensuing Annual General Meeting. 4.During the year, the Nomination & Remuneration Committee has granted 35,000 RSUs on 18th October 2022 to its employees under Newgen Restricted Stock Unit Scheme – 2021. The Committee has also granted 9,41,800 options and 20,000 options to its employees under Newgen ESOP Scheme 2022 and Newgen ESOP Scheme 2014 respectively. 5.A Scheme of Amalgamation u/s 230-232 of the Companies Act, 2013 which provides for the merger of Number Theory Software Private Limited (NTSPL), a wholly owned subsidiary with the Company, has been approved by the Shareholders and unsecured creditors of the Company in their respective meetings convened by NCLT on 24 September 2022, subject to requisite approval(s). The second motion application has been filed and is pending with NCLT. 6.Previous period's figures have been regrouped/reclassified wherever necessary to correspond with the current period's classification/disclosure. Geographical 2022-04-01 2023-03-31 Audited Standalone 8878006000.00 331448000.00 9209454000.00 0.00 0.00 0.00 4271943000.00 38731000.00 191684000.00 2635379000.00 7137737000.00 2071717000.00 0.00 2071717000.00 392982000.00 -20201000.00 372781000.00 0.00 1698936000.00 0.00 0.00 0.00 0.00 1698936000.00 -22466000.00 1676470000.00 -22466000.00 1676470000.00 696557000.00 10 8508228000.00 24.41 24.10 0.00 0.00 24.41 24.10 Other Expenses 725551000.00 Other Expenses 2635379000.00 1637074000.00 0.00 0.00 0.00 584633000.00 0.00 0.00 0.00 369794000.00 0.00 0.00 1909536000.00 2279330000.00 176079000.00 1412000.00 4678528000.00 0.00 1313880000.00 3121140000.00 462636000.00 972932000.00 44235000.00 1281327000.00 7196150000.00 160654000.00 125451000.00 7482255000.00 0.00 0.00 12160783000.00 696557000.00 8508228000.00 9204785000.00 9204785000.00 22005000.00 0.00 246707000.00 268712000.00 342793000.00 0.00 0.00 0.00 611505000.00 20350000.00 557593000.00 435047000.00 1012990000.00 1095602000.00 93625000.00 142276000.00 0.00 2344493000.00 0.00 0.00 2955998000.00 12160783000.00 APAC 311599000.00 EMEA 1055773000.00 India 866612000.00 USA 600454000.00 APAC 1125228000.00 EMEA 3052068000.00 India 3022047000.00 USA 1678663000.00 2834438000.00 8878006000.00 0.00 0.00 2834438000.00 8878006000.00 APAC 107789000.00 EMEA 427885000.00 India 226780000.00 USA 156626000.00 APAC 233292000.00 EMEA 931286000.00 India 639714000.00 USA 199280000.00 919080000.00 2003572000.00 10370000.00 38731000.00 -13310000.00 Unallocated assets, liabilities, revenue and expenses: Certain assets, liabilities, revenue and expenses are not specifically allocable to individual segments as the underlying services are used interchangeably. TheCompany believes that it is not practicable to provide segment disclosures relating to such assets, liabilities, revenue and expenses and accordingly such assets, liabilities, revenue and expenses are separately disclosed as ‘unallocated’. -106876000.00 922020000.00 2071717000.00 APAC 593041000.00 EMEA 2025194000.00 India 1540986000.00 USA 714549000.00 4873770000.00 7287013000.00 12160783000.00 APAC 399298000.00 EMEA 901370000.00 India 736624000.00 USA 280557000.00 2317849000.00 638149000.00 2955998000.00 32678000.00 0.00 -1403298000.00 0.00 -39286000.00 -969000.00 -894000.00 -42434000.00 0.00 249668000.00 0.00 195398000.00 0.00 191684000.00 0.00 30923000.00 8389000.00 -8738000.00 0.00 21186000.00 0.00 205317000.00 122753000.00 -8729000.00 0.00 -15072000.00 0.00 80498000.00 0.00 -791560000.00 1280157000.00 0.00 0.00 0.00 350792000.00 0.00 929365000.00 0.00 67530000.00 925149000.00 1319840000.00 0.00 0.00 0.00 0.00 796000.00 164194000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6730000.00 0.00 0.00 0.00 0.00 149365000.00 0.00 -100231000.00 0.00 -583215000.00 0.00 0.00 0.00 0.00 0.00 0.00 7273000.00 0.00 0.00 23423000.00 90499000.00 0.00 314801000.00 0.00 0.00 0.00 -421450000.00 -75300000.00 0.00 -75300000.00 537936000.00 462636000.00 Remeasurement of defined benefit liability/(asset) 19275000.00 Remeasurement of defined benefit liability/(asset) -1320000.00 19275000.00 -1320000.00 6736000.00 -461000.00 Debt instruments through other comprehensive income - net change in fair value 5175000.00 Debt instruments through other comprehensive income - net change in fair value -28170000.00 5175000.00 -28170000.00 1205000.00 -6563000.00